Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study (Q44846367)
Jump to navigation
Jump to search
scientific article published on 19 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study |
scientific article published on 19 August 2011 |
Statements
1 reference
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study (English)
1 reference
Mark Clemons
1 reference
Marc Tischkowitz
1 reference
Blake Gilks
1 reference
Karen A Gelmon
1 reference
Helen Mackay
1 reference
Kenneth Swenerton
1 reference
André Robidoux
1 reference
Katia Tonkin
1 reference
Hal Hirte
1 reference
David Huntsman
1 reference
Rinat Yerushalmi
1 reference
Euan Macpherson
1 reference
James Carmichael
1 reference
Amit Oza
1 reference
19 August 2011
1 reference
1 reference
12
1 reference
852-861
1 reference
9
1 reference
Identifiers
1 reference
1 reference